Anti-estrogen Steroids Tamoxifen Citrate Nolvadex Bulking Cycle Steroids Powder

Anti-estrogen Steroids Tamoxifen Citrate Nolvadex Bulking Cycle Steroids Powder


Tamoxifen Citrate(Nolvadex)
CAS NO.:10540-29-1
EINECS: 259-415-2
Molecular Formula: C26H29NO
Molecular Weight: 371.51
MP: 140-144 oC
Purity: 99.5%
Standard:USP
Appearance: White crystalline powder .
Usage:Breast cancer and oophoroma.
Packing: 25kgs drum/ aluminium tin or as required.
MOQ: 10g
Payment: Western Union, MoneyGram
Shipment: EMS, DHL, FedEx, TNT
Delivery: safe & timely, around 7days after payment


Description:

Nolvadex is an estrogen agonist in the liver, capable of activating the estrogen receptor and mimicking the actions of this sex hormone in this region of the body. As such it can have a markedly positive impact on HDL (good) cholesterol values, as does estrogen. Many similarly use this drug to counter some of the negative consequences of steroid use in regards to cholesterol values and cardiac risk, as steroids often suppress HDL and raise LDL levels considerably. in some instances an athlete is able to maintain a very favorable HDL/LDL cholesterol ratio, to spite the use of a mode rate dosage (400mg weekly) of an injectable like testosterone or nandrolone. It would be foolish to think however that Nolvadex would be a sufficient remedy with the heavy use of c-l7alpha alkylated orals or extremely high dosed cycles in general

The drug is technically an estrogen agonist/antagonist, which competitively binds to estrogen receptors in various target tissues. With the tamoxifen molecule bound to this receptor, estrogen is blocked from exerting any action, and an anti-estrogenic effect is achieved. Since many forms of breast cancer are responsive to estrogen, the ability of tamoxifen citrate to block its action in such cells has proven to be a very effective treatment.

It is also utilized successfully as a preventative measure, taken by people with an extremely high familial tendency for breast cancer. While Nolvadex is effective against estrogen, it is not our strongest available remedy. We now have the drugs Arimidex, Femara, and Aromasin available to us, which notably prevents estrogen from being manufactured in the first place. Altering the effect of estrogen in the female body can cause a level of discomfort, so anti-estrogens are most bearable when used after the point of menopause. Since Nolvadex is milder in comparison, it is more widely applicable and usually the first treatment option.


Application:

The claim that Nolvadex reduces gains should not be taken too seriously. The fact is that any number of bodybuilders have made excellent gains while using Nolvadex. The belief that it reduces gains seems to stem from the fact that the scientific literature reports a slight reduction in IGF-1 (individuals using anabolic steroids were not studied though) from use of Nolvadex.

Tamoxifen slows or stops the growth of cancer cells that are already present in the body. It helps keep the original breast cancer from coming back and helps prevent new cancer in the opposite breast. It also reduces the risk of breast cancer in women who have a high risk for this disease.

Tamoxifen is highly effective in lowering the risk of breast cancer recurrence. In women who have already had breast cancer, tamoxifen also lowers the risk of breast cancer in the opposite breast (contralateral).Tamoxifen is used to prevent and treat breast cancers that test positive for estrogen receptors (ER+). It blocks the effects that the hormone estrogen has on cancer cells and lowers the chance that breast cancer will grow. It is often called an "anti-estrogen."For postmenopausal women, a two-stage treatment using tamoxifen and then an aromatase inhibitor, such as anastrozole (Arimidex), exemestane (Aromasin), or letrozole (Femara) may work better than only taking tamoxifen.

If you are interested in our products, feel free to contact us:

Skype: holybiological02
Email: holybiological02@holybiological.com

Welcome to your inquiry!

Permanent link: http://www.vvchem.com/sell/cas:10540-29-1,3315094.html